Vitamin D Can Increase Pathological Response of the Breast Cancer Patients Treated With Neoadjuvant Therapy

• Status: Recruiting
• Trial end date: 2020-12-10
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of the study is to evaluate the relationship between the vitamin D replacement and pathological response in patients undergoing neoadjuvant therapy according to different molecular sub types. Because of no study evaluating pathological response to neoadjuvant therapy with vitamin D replacement in patients with breast cancer.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Florence Nightingale Hospital, Istanbul
• Treatments: Cholecalciferol; Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Invasive breast cancer is confirmed by biopsy

• enough organ function,

• metabolically normal,

• eligible for neoadjuvant treatment

• The patients who were informed about the prerequisites with their consent

Exclusion Criteria:

• having metastatic disease

• having not operated from breast cancer after neoadjuvant treatment